Mumbai (Maharashtra) [India], January 13: Medicamen Organics Limited (MOL) (NSE- MEDIORG) one of the leading manufacturers of pharmaceutical and health products, has announced the issuance and allotment of 4,65,910 convertible warrants on a preferential basis to the promoter group of the company. This move aims to raise ₹ 3 Cr, which will be utilized to strengthen the company’s […]
Continue Reading
Mumbai (Maharashtra) [India], January 04: Medicamen Organics Limited (MOL) (NSE- MEDIORG) one of the leading manufacturers of pharmaceuticals and health products, is pleased to announce the incorporation of a new subsidiary, Grande Etoile Pharmaceuticals Limited (GEPL). GEPL, established as a public limited company in India, has an initial authorised capital of ₹ 1 Cr and paid-up share capital […]
Continue Reading
New Delhi [India], November 19: Medicamen Organics Limited (MOL) (NSE- MEDIORG) one of the prominent players in the pharmaceutical sector specializing in the development, manufacturing, and distribution of an extensive range of pharmaceutical dosages has announced its Unaudited H1 FY25 results Key Financial Highlights H1 FY25 • Total Revenue of ₹ 1,685.66 Lakhs, YoY growth of 48.91% • EBITDA of ₹ 277.44 Lakhs, […]
Continue Reading
Mumbai (Maharashtra) [India], October 9: Medicamen Organics Limited (MOL) (NSE- MEDIORG), one of the prominent players in the pharmaceutical sector, specialising in the development, manufacturing, and distribution of an extensive range of pharmaceutical dosage forms, is pleased to announce the signing of a Definitive Share Purchase Agreement on October 08, 2024, for the acquisition of […]
Continue Reading